Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Operations (Details) - Schedule of purchase price of the acquisition

v3.22.2.2
Organization and Nature of Operations (Details) - Schedule of purchase price of the acquisition - USD ($)
 9 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Consideration:    
Fair value of equity received $ 7,240,222  
Liabilities assumed 2,987,152  
Loans forgiven 605,311  
Total consideration 10,832,685  
Goodwill 913,184 $ 913,184
Merger Agreement [Member]    
Tangible Assets Acquired:    
Net Tangible Assets Acquired (1,193,499)  
Licenses and trademarks    
Net Intangible Assets Acquired 11,113,000  
Patent products    
Total Fair Value of Assets Acquired 9,919,501  
Net working capital [Member] | Merger Agreement [Member]    
Tangible Assets Acquired:    
Net Tangible Assets Acquired (1,186,622)  
Right of Use Asset [Member] | Merger Agreement [Member]    
Tangible Assets Acquired:    
Net Tangible Assets Acquired 40,093  
Lease Liability [Member] | Merger Agreement [Member]    
Tangible Assets Acquired:    
Net Tangible Assets Acquired (46,970)  
Brain Scientific Trade Name [Member] | Merger Agreement [Member]    
Licenses and trademarks    
Net Intangible Assets Acquired 133,000  
MemoryMD Trade Name [Member] | Merger Agreement [Member]    
Licenses and trademarks    
Net Intangible Assets Acquired 504,000  
Neurocap Trade Name [Member] | Merger Agreement [Member]    
Licenses and trademarks    
Net Intangible Assets Acquired 188,000  
Neuro EEG Trade Name [Member] | Merger Agreement [Member]    
Licenses and trademarks    
Net Intangible Assets Acquired 11,000  
NeuroEEG Developed Technology [Member] | Merger Agreement [Member]    
Licenses and trademarks    
Net Intangible Assets Acquired 35,000  
NeuroCap Developed Technology [Member] | Merger Agreement [Member]    
Licenses and trademarks    
Net Intangible Assets Acquired $ 10,242,000